Alzheimer's Disease International (ADI)
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
Lecanemab is the first therapy of its kind approved in the EU that could potentially slow the progression of Alzheimer’s disease. The use of lecanemab will now be considered by national payers, who will assess the treatment against further nationally determined criteria.
This comes as the Appeals board of the European Commission were unable to reach a verdict following the “no opinion” decision of the Standing Committee on Medicinal Products for Human Use and the European Commission. The matter will now be referred the European Commission for a final decision.
This page has been set up in response to the crisis taking place in Ukraine. Here you can find an overview of resources and support for people who have been affected by the crisis, directly and indirectly. We will be adding to this page regularly.
Researchers from University College London (UCL) summarise their recently published study which explores the consideration of minority characteristics within pre-existing clinical practice guidelines for dementia.
ADI is pleased to announce the formalisation of a long-standing collaboration with World Wide-FINGERS (WW-FINGERS) by joining in partnership to reduce the risk of dementia worldwide.
In this blog from Meredith Gresham of COGNISANCE, Meredith outlines how the Forward with Dementia campaign is helping to provide hope and support for people living with dementia and carers, as well as tools for more effective post-diagnostic support, in 5 countries.
In this blog, the World Alzheimer Report 2020 authors discuss the creation of a new national dementia plan guide which aims to aid policymakers and interested people looking to include dementia-related design in their own national dementia plans.
In this blog, Amalia Fonk-Utomo writes about her experience as Head of Accreditation and the journey to Kiang Wu Nursing College of Macau becoming the first ADI Accredited body.
ADI delivered important statements to the World Health Organization (WHO) and Member States on the importance of considering those living with dementia and carers in pandemic responses, humanitarian crises, as well as a new neurological global action plan.
In this blog from Maree McCabe, CEO of Dementia Australia, Maree writes about the organisation's dementia friendly communities programme and how people living with dementia are spearheading its success.